Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Liver Cancer|April 18, 2018
Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk AssessmentFabio Piscaglia, Sadahisa Ogasawara
BMC Cancer|August 15, 2019
Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT studyRebecca A Miksad, Sadahisa Ogasawara, Fang Xia, et al.
World Journal of Hepatology|August 6, 2015
Current management of patients with hepatocellular carcinomaTatsuo Kanda, Sadahisa Ogasawara, Tetsuhiro Chiba, et al.
Internal Medicine (Tokyo, Japan)|July 17, 2024
A Comparison of the Effects of Alcohol Abstinence and Drinking Habit on the Survival of Patients with Alcohol-related Cirrhosis: A Retrospective Observational StudyHidehiro Kamezaki, Terunao Iwanaga, Takahiro Maeda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|November 13, 2025
Incidence and Short-Term Prognosis of Acute-On-Chronic Liver Failure Defined by Japanese Criteria: A Single-Center Retrospective Cohort Study From Urban JapanHidehiro Kamezaki, Terunao Iwanaga, Takahiro Maeda, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|April 20, 2024
Relationship between hand-foot skin reaction and external force on patients with hepatocellular carcinoma: A cohort studyYukie Tahara, Ayumi Amemiya, Ryutaro Kase, et al.
Biomed Research International|October 10, 2014
Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopeniaYoshihiko Ooka, Tetsuhiro Chiba, Sadahisa Ogasawara, et al.
World Journal of Hepatology|August 12, 2015
Biological features and biomarkers in hepatocellular carcinomaTetsuhiro Chiba, Eiichiro Suzuki, Tomoko Saito, et al.
Hepatology International|July 24, 2015
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinomaSadahisa Ogasawara, Fumihiko Kanai, Yoshihiko Ooka, et al.
Plos One|August 19, 2016
Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular CarcinomaSadahisa Ogasawara, Tetsuhiro Chiba, Yoshihiko Ooka, et al.
Pageof 16